|
|
|
|
| B-30Eye-1 | Retinoblastoma with adjacent normal eye tissue array, including TNM and clinical stage, 15 cases/30 cores | | Cores | 30 | Cases | 15 | | Row number | 5 | Column number | 6 | | Core Diameter(mm) | 1.5 | Thickness(µm) | 5.0 | | Tissue Array Type | FFPE | Species | Human | | QA/QC | H&E and IHC confirmed | | Applications | Routine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page. | | Notes | 1.Please keep the slides at 4 ℃ after receiving, and make experiment within 3 months will be better. 2.Bake the slides for 60 minutes at 65℃ before the experiment. 3.Please choose a gentle repair method to avoid tissue detachment. |
|
|
| |
|
Legend:
|
|
Malignant (I) Malignant (IIB) Malignant (IIC) NAT (*) |
|
|
|
| |
| Pos | No | Age | Sex | Organ_Anatomic_Site | Pathology_diagnosis | Grade | TNM | Stage | Type |
| A1 | 1 | 15 | F | Eye | Retinoblastoma | * | T3cN0M0 | IIC | Malignant |
| A2 | 2 | 15 | F | Eye | Retinoblastoma | * | T3cN0M0 | IIC | Malignant |
| A3 | 3 | 7 | M | Eye | Retinoblastoma | * | T2bN0M0 | I | Malignant |
| A4 | 4 | 7 | M | Eye | Retinoblastoma | * | T2bN0M0 | I | Malignant |
| A5 | 5 | 2 | F | Eye | Retinoblastoma | * | T2N0M0 | I | Malignant |
| A6 | 6 | 2 | F | Eye | Retinoblastoma with necrosis | * | T2N0M0 | I | Malignant |
| B1 | 7 | 28 | M | Eye | Retinoblastoma | * | T3cN0M0 | IIC | Malignant |
| B2 | 8 | 28 | M | Eye | Retinoblastoma with necrosis | * | T3cN0M0 | IIC | Malignant |
| B3 | 9 | 3 | M | Eye | Retinoblastoma (sparse) | * | T2N0M0 | I | Malignant |
| B4 | 10 | 3 | M | Eye | Retinoblastoma with necrosis | * | T2N0M0 | I | Malignant |
| B5 | 11 | 74 | M | Eye | Retinoblastoma | * | T2N0M0 | I | Malignant |
| B6 | 12 | 74 | M | Eye | Retinoblastoma | * | T2N0M0 | I | Malignant |
| C1 | 13 | 27 | M | Eye | Retinoblastoma | * | T2N0M0 | I | Malignant |
| C2 | 14 | 27 | M | Eye | Retinoblastoma | * | T2N0M0 | I | Malignant |
| C3 | 15 | 5 | M | Eye | Retinoblastoma (sparse) | * | T2N0M0 | I | Malignant |
| C4 | 16 | 5 | M | Eye | Retinoblastoma (sparse) | * | T2N0M0 | I | Malignant |
| C5 | 17 | 70 | M | Eye | Retinoblastoma | * | T3bN0M0 | IIB | Malignant |
| C6 | 18 | 70 | M | Eye | Retinoblastoma with necrosis | * | T3bN0M0 | IIB | Malignant |
| D1 | 19 | 55 | F | Eye | Adjacent normal eye tissue (retina, choroid, sclera) | * | * | * | NAT |
| D2 | 20 | 55 | F | Eye | Adjacent normal eye tissue (retina, choroid, sclera) | * | * | * | NAT |
| D3 | 21 | 62 | M | Eye | Adjacent normal eye tissue (retina, choroid, sclera) | * | * | * | NAT |
| D4 | 22 | 62 | M | Eye | Adjacent normal eye tissue (sclera) | * | * | * | NAT |
| D5 | 23 | 66 | M | Eye | Adjacent normal eye tissue (retina, choroid, sclera) | * | * | * | NAT |
| D6 | 24 | 66 | M | Eye | Adjacent normal eye tissue (retina, choroid, sclera) | * | * | * | NAT |
| E1 | 25 | 2 | F | Eye | Adjacent normal eye tissue (choroid) | * | * | * | NAT |
| E2 | 26 | 2 | F | Eye | Adjacent normal eye tissue (choroid) | * | * | * | NAT |
| E3 | 27 | 44 | M | Eye | Adjacent normal eye tissue (eyelid) | * | * | * | NAT |
| E4 | 28 | 44 | M | Eye | Adjacent normal eye tissue (retina, choroid, sclera) | * | * | * | NAT |
| E5 | 29 | 13 | M | Eye | Adjacent normal eye tissue (retina, choroid, sclera) | * | * | * | NAT |
| E6 | 30 | 13 | M | Eye | Adjacent normal eye tissue (retina, choroid, sclera) | * | * | * | NAT | | Tissue Marker |
|
|
